These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2897781)

  • 1. Transient myocardial ischemia after abrupt withdrawal of antianginal therapy in chronic stable angina.
    Egstrup K
    Am J Cardiol; 1988 Jun; 61(15):1219-22. PubMed ID: 2897781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and research applications of ambulatory Holter ST-segment and heart rate monitoring.
    Bala Subramanian V
    Am J Cardiol; 1986 Aug; 58(4):11B-20B. PubMed ID: 2875642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
    Deedwania PC; Carbajal EV
    Am J Cardiol; 1990 May; 65(16):1090-6. PubMed ID: 1970449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent ischemia and beta-blockade.
    Egstrup K
    Circulation; 1991 Dec; 84(6 Suppl):VI84-92. PubMed ID: 1683614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of therapy in chronic ischemic heart disease.
    Fox KM; Levy RD; Quyyumi AA
    Am J Cardiol; 1987 Jul; 60(2):33A-35A. PubMed ID: 2887099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
    Dargie HJ; Ford I; Fox KM
    Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic blocker withdrawal.
    Frishman WH
    Am J Cardiol; 1987 May; 59(13):26F-32F. PubMed ID: 2883874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of silent myocardial ischemia in patients with unstable angina.
    Nademanee K; Intarachot V; Josephson MA; Rieders D; Vaghaiwalla Mody F; Singh BN
    J Am Coll Cardiol; 1987 Jul; 10(1):1-9. PubMed ID: 3597980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 14. Asymptomatic myocardial ischemia as a predictor of cardiac events after coronary artery bypass grafting for stable angina pectoris.
    Egstrup K
    Am J Cardiol; 1988 Feb; 61(4):248-52. PubMed ID: 3257631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina.
    Gottlieb SO; Weisfeldt ML; Ouyang P; Mellits ED; Gerstenblith G
    N Engl J Med; 1986 May; 314(19):1214-9. PubMed ID: 2871485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The nifedipine withdrawal syndrome in patients with stable stenocardia of effort].
    Martsevich SIu; Kutishenko NP; Metelitsa VI
    Ter Arkh; 1995; 67(6):8-10. PubMed ID: 7667792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of circadian variation by combined antianginal therapy with suppression of morning and evening increases in transient myocardial ischemia.
    Egstrup K
    Am Heart J; 1991 Sep; 122(3 Pt 1):648-55. PubMed ID: 1877441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Implications for the mechanism of action of beta-blockers.
    Chierchia S; Muiesan L; Davies A; Balasubramian V; Gerosa S; Raftery EB
    Circulation; 1990 Sep; 82(3 Suppl):II71-81. PubMed ID: 1975525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.